Author/Creator: Minini, Pascal - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Minini, Pascal

1. Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia. Issue 3 (May 2017)

Authors:: Kastelein, John J.P.; Kereiakes, Dean J.; Cannon, Christopher P.; Bays, Harold E.; Minini, Pascal; Lee, L. Veronica; Maroni, Jaman; Farnier, Michel
Journal:: Coronary artery disease
Issue:: Volume 28:Issue 3(2017:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials. (15th November 2016)

Authors:: Farnier, Michel; Gaudet, Daniel; Valcheva, Velichka; Minini, Pascal; Miller, Kathryn; Cariou, Bertrand
Journal:: International journal of cardiology
Issue:: Volume 223(2016)
Page Start:: 750
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials. (15th November 2016)

Authors:: Farnier, Michel; Gaudet, Daniel; Valcheva, Velichka; Minini, Pascal; Miller, Kathryn; Cariou, Bertrand
Journal:: International journal of cardiology
Issue:: Volume 223(2016)
Page Start:: 750
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials. (September 2019)

Authors:: Ray, Kausik K.; Vallejo-Vaz, Antonio J.; Ginsberg, Henry N.; Davidson, Michael H.; Louie, Michael J.; Bujas-Bobanovic, Maja; Minini, Pascal; Eckel, Robert H.; Cannon, Christopher P.
Journal:: Atherosclerosis
Issue:: Volume 288(2019)
Page Start:: 194
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Issue 24 (13th December 2016)

Authors:: Ray, Kausik K.; Ginsberg, Henry N.; Davidson, Michael H.; Pordy, Robert; Bessac, Laurence; Minini, Pascal; Eckel, Robert H.; Cannon, Christopher P.
Journal:: Circulation
Issue:: Volume 134:Issue 24(2016)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. SaO002QUANTITATIVE RELATIONSHIP BETWEEN TKV GROWTH RATE AND eGFR RATE OF DECLINE IN ADPKD PATIENTS. (13th June 2019)

Authors:: Minini, Pascal; Hariri, Ali; Maski, Manish; Modur, Vijay
Journal:: Nephrology dialysis transplantation
Issue:: Volume 34(2019)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗